Sectors
TBPH
Theravance Biopharma, Inc.
17.04
2 x 12.14
2 x 21.64
bid
ask
-
0.01
0.06%
2 @ 04:12 PM
17.04 +0.00 (0.00%)
| Ytd | -8.93% | |
| 1y | 22.77% |
17.03
day range
17.08
13.08
52 week range
21.03
| Open | 17.03 | Prev Close | 17.05 | Low | 17.03 | High | 17.08 | Mkt Cap | 884.70M |
| Vol | 383.66K | Avg Vol | 641.20K | EPS | 1.04 | P/E | 16.38 | Forward P/E | 163.17 |
| Beta | 0.25 | Short Ratio | 19.79 | Inst. Own | 96.71% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-10 | 50-d Avg | 16.95 | 200-d Avg | 17.31 | 1yr Est | 13.20 |
| Income Statement | |||
| Total Revenue | 20.73M | ||
| Revenues (USD) | 20.73M | ||
| Gross Profit | 20.73M | ||
| Operating Expenses | 29.01M | ||
| Research and Development Expense | 4.71M | ||
| Selling, General and Administrative Expense | 14.18M | ||
| Operating Income | -8.28M | ||
| Income Tax Expense | 1.11M | ||
| Net Income | -5.90M | ||
| Net Income Common Stock | -5.90M | ||
| Net Income Common Stock (USD) | -5.90M | ||
| Consolidated Income | -5.90M | ||
| Earnings per Basic Share | -0.11 | ||
| Earnings per Basic Share (USD) | -0.11 | ||
| Earnings per Diluted Share | -0.11 | ||
| Earning Before Interest & Taxes (EBIT) | -4.79M | ||
| Earning Before Interest & Taxes (USD) | -4.79M | ||
| Weighted Average Shares | 51.67M | ||
| Weighted Average Shares Diluted | 51.67M | ||
| Balance Sheet | |||
| Cash and Equivalents | 220.60M | ||
| Cash and Equivalents (USD) | 220.60M | ||
| Investments | 167.89M | ||
| Investments Current | 167.89M | ||
| Trade and Non-Trade Receivables | 20.38M | ||
| Current Assets | 416.66M | ||
| Property, Plant & Equipment Net | 27.10M | ||
| Total Assets | 469.77M | ||
| Debt Current | 10.80M | ||
| Total Debt | 38.57M | ||
| Current Liabilities | 30.77M | ||
| Debt Non-Current | 27.77M | ||
| Total Liabilities | 180.07M | ||
| Accumulated Retained Earnings (Deficit) | -870.46M | ||
| Accumulated Other Comprehensive Income | -76.00K | ||
| Shareholders Equity | 289.71M | ||
| Shareholders Equity (USD) | 289.71M | ||
| Assets Non-Current | 53.11M | ||
| Total Debt (USD) | 38.57M | ||
| Liabilities Non-Current | 149.30M | ||
| Trade and Non-Trade Payables | 652.00K | ||
| Tax Liabilities | 88.49M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 1.44M | ||
| Net Cash Flow from Financing | -967.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -68.33M | ||
| Issuance (Purchase) of Equity Shares | -967.00K | ||
| Net Cash Flow from Investing | -60.40M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -60.40M | ||
| Net Cash Flow from Operations | -6.96M | ||
| Share Based Compensation | 5.99M | ||